Allianz Asset Management
JUNO

Allianz Asset Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Allianz Asset Management’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-160,007
Closed -$7.31M – 2818
2017
Q4 		$7.31M Sell
160,007
-22,050
-12% -$1.1M 0.01% 1470
2017
Q3 		$8.17M Buy
+182,057
New +$6.21M 0.01% 1396
2016
Q4 		– Sell
-119,495
Closed -$3.58M – 2732
2016
Q3 		$3.58M Sell
119,495
-45,755
-28% -$1.42M ﹤0.01% 1753
2016
Q2 		$6.35M Buy
165,250
+66,015
+67% +$2.74M 0.01% 1402
2016
Q1 		$3.78M Buy
+99,235
New +$3.46M ﹤0.01% 1553
2015
Q2 		– Sell
-247,153
Closed -$15M – 2570
2015
Q1 		$15M Buy
247,153
+131,503
+114% +$6.38M 0.02% 788
2014
Q4 		$6.04M Buy
+115,650
New +$5.18M 0.01% 1144

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Allianz Asset Management's JUNO Position: Q1 2018 in Review

Allianz Asset Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 160,007 shares — an estimated $7.31M sold.

Allianz Asset Management first reported a position in JUNO in Q4 2014 and held it in 7 quarters. The position peaked at $15M in Q1 2015. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Allianz Asset Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Allianz Asset Management sold 160,007 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $7.31M.
  • Allianz Asset Management first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 7 quarters.
  • Allianz Asset Management's Juno Therapeutics, Inc. position peaked at $15M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Allianz Asset Management's 13F filing for Q1 2018, filed 14 May 2018.